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I M M U N O L O G Y
Control of antiviral innate immune response by protein 
geranylgeranylation
Shigao Yang1, Alfred T. Harding2, Catherine Sweeney1, David Miao1, Gregory Swan1,3, 
Connie Zhou1, Zhaozhao Jiang4, Katherine A. Fitzgerald4, Gianna Hammer3, Martin O. Bergo5, 
Heather K. Kroh6, D. Borden Lacy6,7, Chunxiang Sun8, Michael Glogauer8, Loretta G. Que9, 
Nicholas S. Heaton2, Donghai Wang1,3*
The mitochondrial antiviral signaling protein (MAVS) orchestrates host antiviral innate immune response to RNA 
virus infection. However, how MAVS signaling is controlled to eradicate virus while preventing self-destructive 
inflammation remains obscure. Here, we show that protein geranylgeranylation, a posttranslational lipid modification 
of proteins, limits MAVS-mediated immune signaling by targeting Rho family small guanosine triphosphatase 
Rac1 into the mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) at the mitochondria-ER 
junction. Protein geranylgeranylation and subsequent palmitoylation promote Rac1 translocation into MAMs 
upon viral infection. MAM-localized Rac1 limits MAVS’ interaction with E3 ligase Trim31 and hence inhibits MAVS 
ubiquitination, aggregation, and activation. Rac1 also facilitates the recruitment of caspase-8 and cFLIPL to the 
MAVS signalosome and the subsequent cleavage of Ripk1 that terminates MAVS signaling. Consistently, mice with 
myeloid deficiency of protein geranylgeranylation showed improved survival upon influenza A virus infection. 
Our work revealed a critical role of protein geranylgeranylation in regulating antiviral innate immune response.
INTRODUCTION
In response to RNA virus infection, RIG-I–like receptors (RLRs) in-
duce the aggregation of the mitochondrial antiviral signaling pro-
tein (MAVS) (1, 2) to initiate antiviral innate immune response (3). 
Aggregated MAVS further recruits signaling molecules TRADD 
(4), FADD, Ripk1 (5, 6), cFLIPL (7), and caspase-8 (8, 9) to form a 
large signaling complex—the MAVS signalosome (10), which even-
tually leads to the activation of two cytosolic kinases, TRAF family 
member-associated NFB activator (TANK)–binding kinase 1 (TBK1) 
and IB kinase (IKK), and their downstream transcription factors inter-
feron regulatory factor 3 (IRF3) and nuclear factor B (NFB) (11). RNA 
virus infection induces the K63-linked ubiquitination of Ripk1 with-
in the MAVS signalosome (8, 12). Ubiquitinated Ripk1 recruits the 
NFB essential modulator (NEMO), a component required for the 
activation of TBK1 and IKK (12, 13). MAVS-mediated signaling is 
self-limiting. K63-linked ubiquitination of Ripk1 also renders Ripk1 
susceptible to cleavage by the caspase-8/cFLIPL heterodimer within 
the signaling complex. The resultant 37KD Ripk1 fragment from this 
cleavage inhibits MAVS signaling (8).
The mitochondria-associated endoplasmic reticulum (ER) mem-
branes (MAMs) are the ER membranes at the mitochondria-ER con-
tact sites (MERCs). MAM has attracted increased attention owing 
to its essential function in phospholipid biosynthesis, calcium and 
other ions transferring between ER and mitochondria, the mitochon-
dria bioenergetics, and the initiation of autophagosome formation 
(14). In the event of RNA virus infection, the MAVS signalosome forms 
at the junction between MAM and mitochondria by recruiting RLRs 
and other signaling components into this subcellular location to form 
a signaling synapse (15). However, the detailed molecular mechanisms 
by which MAVS signaling is regulated at the innate immune syn-
apse remain to be elucidated.
Protein geranylgeranylation is a posttranslational modification 
of proteins using the mevalonate pathway metabolite geranylgeranyl 
pyrophosphate (GGPP) as a ligand (16). Protein geranylgeranylation 
is catalyzed by protein geranylgeranyl transferase–I (GGTase-I). 
Using a mouse strain with myeloid deficiency of GGTase-I  sub-
unit (Pggt1b), we report here that protein geranylgeranylation limits 
the MAVS-mediated antiviral innate immune response by targeting 
the Rho family small guanosine triphosphatase (GTPase) Rac1 to 
MAM. MAM-localized Rac1 engages directly with the MAVS sig-
nalosome and restricts the interaction between Trim31 and MAVS 
and thereby limits MAVS K63-linked ubiquitination and subsequent 
aggregation and activation. Furthermore, Rac1 also promotes the 
recruitment of caspase-8 and cFLIPL to the MAVS signalosome and 
hence facilitates the cleavage of ubiquitinated Ripk1 to terminate 
MAVS signaling.
RESULTS
Protein geranylgeranylation negatively regulates  
RLR-mediated antiviral innate immune response
To study whether protein geranylgeranylation regulates innate im-
mune responses mediated by intracellular nucleic acid sensors, bone 
marrow–derived macrophages (BMDMs) from Pggt1bfl/fl Lyz2-Cre 
or Pggt1b+/+Lyz2-Cre mice were transfected with ligands to RIG-I, 
Sting, and cGAS. The transcription of type I interferons Ifnb1 and 
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Ifna4, as well as proinflammatory cytokines Il6 and Tnf, was increased 
in Pggt1b-deficient cells compared to wild-type controls in response to 
stimulation with RIG-I ligands 5′ppp-dsRNA and polyinosinic: 
polycytidylic acid low molecular weight [poly(I:C) LMW], but not 
with Sting ligand 2′3′-cGAMP (cyclic guanosine monophosphate–
adenosine monophosphate) or cGAS (cGAMP synthase) ligand ISD 
(interferon-stimulating DNA) (Fig. 1, A and B). Sendai virus (SeV, 
an RNA virus) infection–induced transcription of Ifnb1, Ifna4, Il6, 
and Tnf in Pggt1b-deficient BMDMs was also enhanced compared to 
wild-type controls (Fig. 1C) but not that induced by mouse cytomeg-
alovirus (MCMV, a DNA virus) infection (fig. S1, A and B). The aug-
mented production of cytokines was not caused by higher replication 
of SeV since the amount of the SeV-P gene was lower in Pggt1b- deficient 
BMDMs (Fig. 1C). The augmented transcription was consistent with 
elevated levels of cytokines in the supernatant of Pggt1b-deficient 
BMDMs infected with SeV (Fig. 1D). Together, these results indicate 
that protein geranylgeranylation suppresses MAVS but not Sting- 
mediated innate immune signaling pathways.
Protein geranylgeranylation inhibits RLR  
downstream signaling
Consistent with augmented production of type I interferons and other 
cytokines, phosphorylation of IRF3, TBK1, and IKK was enhanced 
in Pggt1b-deficient BMDMs transfected with poly(I:C) LMW (Fig. 1E) 
or infected with SeV (Fig. 1F) compared to wild-type controls. How-
ever, phosphorylation of IRF3 and IKK was not enhanced in response 
to cGAS ligand ISD (fig. S1C) or infection with DNA virus MCMV 
(fig. S1D). We have previously shown that activation of the phos-
phoinositide 3-kinase (PI3Kinase)–Akt–Gsk3 signaling axis by 
Toll-like receptors was compromised in Pggt1b-deficient BMDMs 
(17). However, poly(I:C) LMW– or ISD-induced activation of Akt 
and Gsk3 was not substantially changed in Pggt1b-deficient BMDMs 
compared to wild-type controls (fig. S1, E and F). Together, these 
data suggest that protein geranylgeranylation inhibition of RLR- 
mediated innate immune signaling is independent of the PI3Kinase-Akt 
signaling axis.
Rho GTPase Rac1 inhibition of MAVS-mediated signaling 
depends on protein geranylgeranylation
To study the molecular mechanisms by which protein geranylgerany l-
ation regulates MAVS signaling, we focused on GGTase-I substrates. 
Rho family small GTPases Rac1 and Rac2 are typical GGTase-I sub-
strates. When wild-type, Rac1−/−, or Rac2−/− immortalized BMDMs 
(iBMDMs) were infected with SeV, only Rac1−/− but not Rac2−/− 
iBMDMs showed increased transcription of Ifnb1 and Il6 compared 
to wild-type controls, mimicking the phenotype of Pggt1b-deficient 
Fig. 1. Protein geranylgeranylation negatively regulates RLR-mediated antiviral innate immune response. (A to C) Quantitative reverse transcription polymerase 
chain reaction (RT-PCR) analysis of cytokine genes or SeV-P gene transcript abundance from Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs after transfection of mock 
or RIG-I ligands [poly(I:C) LMW and 5′ppp-dsRNA (1 g/ml)], Sting ligand 2′3′-cGAMP (8 g/ml), and cGAS ligand ISD (1 g/ml) with Lipofectamine for 4 hours (A and B), or 
after infection with SeV (50 HA (Hemagglutinin) units/ml in all succeeding experiments) for 4 hours (C); fold, fold change relative to wild-type negative control throughout. 
(D) Enzyme-linked immunosorbent assay (ELISA) measurement of interferon- (IFN-) and interleukin-6 (IL-6) in supernatants of Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre 
BMDMs infected with SeV for 24 hours. (E and F) Immunoblot analysis of phosphorylated (p-) or total IRF3, TBK1, IKK, and Pggt1b or -actin (loading control throughout) 
in Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs transfected with poly(I:C) LMW (E) or infected with SeV (F). Numbers below lanes indicate densitometry of phospho-
rylated IRF3, TBK1, or IKK relative to that of total IRF3, TBK1, or IKK, respectively. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 [two-way analysis of variance (ANOVA)]. 
ns, not significant. Data are representative of three independent experiments with three biological replicates.
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macrophages (Fig. 2, A to C). Phosphorylation of IRF3 and IKK in 
Rac1−/− iBMDM was also enhanced compared to that in wild-type 
controls (Fig. 2D). These results suggest that Rac1 but not Rac2 is 
an inhibitor of RLR signaling. To further evaluate the role of protein 
geranylgeranylation in Rac1 regulation of RLR signaling, Rac1−/− 
iBMDMs were reconstituted with various mutant forms of Rac1. 
Reconstitution with wild-type and the constitutively active G12V 
Rac1 inhibited SeV infection–induced Ifnb1 and Il6 transcription 
Fig. 2. MAM-localized Rac1 inhibits RLR signaling in a protein geranylgeranylation–dependent manner. (A to C) Quantitative RT-PCR analysis of transcript abundance 
of Ifnb1, Il6, Rac1, and Rac2 in wild-type (WT), Rac1−/−, or Rac2−/− iBMDMs 4 hours after SeV infection. (D) Immunoblot of phospho-IRF3 and phospho-IKK in cell lysates of 
wild-type or Rac1−/− iBMDMs following SeV infection. Numbers below lanes indicate densitometry of phosphorylated IRF3 or IKK relative to that of total IRF3 or IKK, 
respectively. (E to H) Quantitative RT-PCR analysis of transcript abundance of Ifnb1, Il6, and SeV-P (E to G) and immunoblot of Rac1 (H) in Rac1−/− iBMDMs reconstituted with 
wild-type, C189S, G12V, or G12V/C189S of Rac1 4 hours after SeV infection. (I and J) Confocal microscopy of immunofluorescent staining of Rac1 (green) and SIGMA1R (red) 
in Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs 4 hours after SeV infection. Cells were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue). Scale bars, 10 m 
(I). See each single channel in fig. S3J. The percentage of colocalization between Rac1 and SIGMA1R was calculated using the ImageJ software from at least 50 cells randomly 
selected from the immunostaining slides (J). (K to N) Representative PLA images of Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs (K) or Rac1−/− iBMDMs reconstituted 
with wild-type, G12V, or C189S of Rac1 (M) 4 hours after SeV infection. The cells were probed with Rac1 and SIGMA1R antibodies. Red spots indicate the association of Rac1 
with SIGMA1R. (K and M) Cells were counterstained with DAPI (blue). Scale bars, 10 m. (L and N) Quantitation of PLA spots per cell in (K) and (M) (n = 20 cells). (O) Schematic 
display of the C-terminal amino acid sequence of Rac1 highlighting the C178 for palmitoylation and C189 for geranylgeranylation sites. (P) Immunoblots of Rac1 after 
S-palmitoylated protein assay (acyl-RAC; see Materials and Methods) of captured proteins (Pulldown) and inputs from Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDM cell 
lysate following infection with or without SeV for 4 hours. (Q) Quantitative RT-PCR of Ifnb1 and Il6 abundance in MEF cells stably expressing wild-type and C178S mutant 
forms of Rac1 after transfection with poly(I:C) LMW. **P < 0.01, ****P < 0.0001 (two-way ANOVA). Data are representative of three independent experiments.
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that correlated with more viral propagation, whereas the non- 
geranylgeranylated C189S (18) did not (Fig. 2, E to G) although the 
expression level of C189S Rac1 was much higher than its wild-type 
or G12V counterpart (Fig. 2H). The G12V/C189S double mutant 
failed to inhibit cytokine production in reconstituted cells (Fig. 3, E   
and F), indicating that protein geranylgeranylation is required for 
the inhibitory effects of Rac1. The wild-type, G12V, and C189S Rac1 
mutants were also stably expressed in mouse embryonic fibroblasts 
(fig. S2A). Stable expression of wild-type and G12V Rac1 inhibited 
RIG-I ligand poly(I:C) LMW transfection–induced transcription of 
Ifnb1 and Il6, whereas the non-geranylgeranylated C189S mutant 
Rac1 failed to do so (fig. S2, B and C). Together, these data suggest 
that Rac1 inhibits MAVS signaling in a protein geranylgeranylation–
dependent manner.
Deficiency of another Rho family member, RhoA, in BMDMs did 
not significantly increase the innate immune response to SeV infec-
tion (fig. S2, D to F). Expression of RhoA was not completely abrogated 
in RhoAfl/fl Lyz2-Cre BMDMs presumably owing to counter selection 
of RhoA-deficient cells (fig. S2G). When wild-type BMDMs were 
treated with the clostridial glucosylating lethal toxin TcsL from 
Clostridium sordellii that inactivates Rac and Cdc42 (19), produc-
tion of type I interferons in response to SeV infection was enhanced 
(fig. S2H). Treatment of wild-type BMDMs with a Rac-specific in-
hibitor, EHT1864 (20), enhanced type I interferon transcription 
(fig. S2I), whereas treatment of BMDMs with a Cdc42-specific in-
hibitor, ML141 (21), did not affect macrophages’ innate immune 
response to viral infection (fig. S2J), suggesting that Cdc42 is 
not involved in the regulation of innate immune response to viral 
Fig. 3. Rac1 directly engages MAVS signalosome and inhibits MAVS signaling in a protein geranylgeranylation–dependent manner. (A) Immunoblots (IB) of MAVS 
and TRADD in anti-Rac1 immunoprecipitates (IP) from the mitochondrial fraction of BMDMs infected with or without SeV. IgG, immunoglobulin G; VDAC, voltage-dependent 
anion channel. (B and C) Confocal microscopy of immunofluorescent staining of Rac1 (green) and MAVS (red) in BMDMs 4 hours after infection with SeV. Scale bars, 
10 m (B). See each single channel in fig. S5A. The percentage of colocalization of Rac1 and MAVS was calculated using ImageJ (C). (D to G) Representative PLA confocal 
images for Rac1 and MAVS in Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs (D) or Rac1−/− iBMDMs reconstituted with wild-type, G12V, or C189S of Rac1 (F) 4 hours 
after SeV infection. Cells were counterstained with DAPI (blue). Scale bars, 10 m (D and F). (E and G) Quantification of PLA spots per cell in (D) and (F) (n = 20 cells). 
(H) Luciferase activity in 293T cell lysate 24 hours after transfection with an IFN- luciferase reporter, HA-MAVS together with wild-type, G12V, or C189S Rac1 (top). Immu-
noblots of HA-MAVS and Rac1 in whole-cell lysates (WCL) of transfected 293T cells (bottom). (I) Immunoblot of crude mitochondrial and cytoplasm fractions from 293T cells 
cotransfected with Myc-MAVS and Flag-Rac1 wild-type, G12V, or C189S mutants with indicated antibodies. (J) Schematic of MAVS (wild-type) and its truncation mutants 
(top), and coimmunoprecipitation analysis of the interaction of Flag-Rac1 with Myc-MAVS or its truncation mutants in 293T cells (bottom). **P < 0.01, ***P < 0.001, ****P < 
0.0001 (two-way ANOVA). Data are representative of three independent experiments.
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infection. Together, Rac1 likely plays a dominant role in limiting 
RLR signaling.
Viral infection–induced MAM translocation of Rac1  
depends on protein geranylgeranylation and  
subsequent palmitoylation
Mitochondrial anchorage of MAVS is essential for its innate immune 
function (2). Rho GTPases are conventionally thought to be either 
membrane-associated or cytosolic when bound to Rho-GDI (Rho 
GDP-dissociation inhibitor) (22). Since MAVS-mediated innate 
immune response happens at the MAM-mitochondria junction (15), 
we speculated that Rac1 might be recruited to MAM to engage with 
the MAVS signalosome. To test this hypothesis, Pggt1bfl/fl Lyz2-Cre 
or Pggt1b+/+Lyz2-Cre BMDMs infected with or without SeV were frac-
tionated into crude mitochon dria or cytosolic fractions and subjected 
to Western blot. Two MAM markers, FACL4 and SIGMA1R (23, 24), 
were readily detected in the crude mitochondrial fraction (fig. S3A), 
indicating that the crude mitochondrial fraction contains MAM 
protein components as reported earlier (15). Rac1 was also recovered 
in the crude mitochondrial fraction from wild-type, but to a much 
lower level than that from Pggt1b-deficient BMDMs (fig. S3A). The 
amount of Rac1 in the crude mitochondrial fraction was further in-
creased upon SeV infection only in wild-type but not mutant BMDMs, 
suggesting that SeV infection–induced enrichment of Rac1 in the 
crude mitochondrial fraction depends on protein geranylgeranylation 
(fig. S3, A and B). Nevertheless, RIG-I enrichment in the mitochondrial 
crude extract was not affected by Pggt1b deficiency, suggesting that 
protein geranylgeranylation regulates RLR signaling downstream 
of RIG-I (fig. S3, A to C). It is notable that when cells were fractionated, 
the total amount of Rac1 in both the crude mitochondrial and cytosolic 
fractions was less in Pggt1b-deficient macrophages compared to wild-
type controls. This raised the possibility that Rac1 expression or 
stability is regulated by protein geranylgeranylation. Western blot of 
total cell lysate with an anti-Rac1 antibody indicated that there was 
equal amount of Rac1 in Pggt1b-deficient cells and wild-type control cells 
(fig. S3, D and E). We believe that the phenomenon of lower recovery 
of Rac1 from Pggt1b-deficient crude mitochondrial and cytosolic frac-
tions was due to fractionation of part of the non- geranylgeranylated 
Rac1 into the nuclear fraction. RIG-I ligand poly(I:C) LMW trans-
fection induced similar effects of Rac1 enrichment in the crude 
mitochondrial fraction from wild-type BMDMs, and such enrichment 
happened in a protein geranylgeranylation–dependent manner (fig. S3, 
F and G). In line with the biochemical results, confocal microscopy 
analysis showed that Rac1 was brought to the proximity of mitochon-
dria in a Pggt1b-dependent manner (fig. S3, H and I). To fur-
ther verify whether Rac1 in the crude mitochondrial fraction is 
actually on MAMs, we used confocal microscopy to determine whether 
Rac1 colocalizes with MAM markers SIGMA1R and FACL4. Con-
focal microscopy analysis indicates that Rac1 was randomly distrib-
uted in the unprovoked cells. SeV infection induced colocalization 
of Rac1 with MAM markers SIGMA1R and FACL4. Such colocal-
ization was abrogated in the absence of Pggt1b (Fig. 2, I and J, and 
fig. S3, J to L). These observations indicate that Rac1 translocates 
into MAMs upon SeV infection in a protein geranylgeranylation–
dependent manner.
The chaperon protein SIGMA1R is a MAM marker that has been 
shown to interact with Rac1 (25). We speculated that SIGMA1R might 
serve as an anchor to recruit Rac1 into MAM upon viral infection. 
We used in situ proximity ligation assay (PLA) to assess the interac-
tion between Rac1 and SIGMA1R. Rac1 and SIGMA1R were induc-
ibly associated with each other upon SeV infection in wild-type but not 
Pggt1b-deficient BMDMs (Fig. 2, K and L). PLA analysis of Rac1−/− 
iBMDMs reconstituted with various mutant forms of Rac1 showed 
that only wild-type and G12V but not the non-geranylgeranylated 
C189S mutant Rac1 could interact with SIGMA1R in macrophages 
upon viral infection (Fig. 2, M and N), further supporting the no-
tion that viral infection–induced Rac1 interaction with SIGMA1R 
depends on protein geranylgeranylation of Rac1. Together, Rac1 is 
recruited into MAM upon viral infection where it is associated with 
MAM-resident protein SIGMA1R in a protein geranylgeranylation–
dependent manner.
SIGMA1R receptor agonists such as N,N-dimethyltryptamine 
(NN-DMT) can activate SIGMA1R signaling and modulate innate 
immune response (26). NN-DMT treatment did not alter SeV-induced 
cytokine production (fig. S4, A to C). However, RNAi knockdown 
of SIGMA1R in primary BMDMs led to enhanced innate immune 
response to SeV infection (fig. S4, D to G). Together, it is highly 
likely that the chaperon but not the signaling function of SIGMA1R 
is important for anchoring Rac1 to MAM to execute the immune 
suppressive activity.
The MAMs are enriched with cholesterols (27). Protein palmitoyla-
tion facilitates modified protein translocation to the cholesterol-enriched 
microdomains within MAMs (28). Viral infection causes ER stress 
and increases protein palmitoylation (29). It has been reported that 
Rac1 can be palmitoylated at Cys178 (Fig. 2O) that facilitates Rac1 
translocation into cholesterol-enriched lipid microdomains and that 
Rac1 palmitoylation depends on prior geranylgeranylation (30). On 
the basis of these previous findings, we speculated that viral infection 
might induce the palmitoylation and subsequent translocation of Rac1 
to the cholesterol-rich MAM. SeV infection induced palmitoylation 
of Rac1 in wild-type but not Pggt1b-deficient BMDMs (Fig. 2P). 
When stably expressed in mouse embryonic fibroblast (MEF) cells, 
C178S mutant Rac1 failed to inhibit transfected poly(I:C) LMW–
induced Ifnb1 and Il6 transcription (Fig. 2Q). Consistent with these 
findings, confocal microscopy showed that C178S mutant Rac1 failed 
to colocalize with MitoTracker or the MAM marker FACL4 upon 
SeV infection (fig. S4, H and I). Together, these data indicate that 
protein geranylgeranylation and subsequent palmitoylation target 
Rac1 into MAM upon viral infection.
MAM-localized Rac1 directly engages MAVS signalosome 
and inhibits MAVS signaling in a protein 
geranylgeranylation–dependent manner
When activated, MAVS forms a signaling complex on the mitochondria 
that includes TRADD, termed TRADDosome (4). We reasoned that 
MAM-localized Rac1 might directly interact with the MAVS signal-
ing complex on the mitochondria given the close proximity between 
MAM and mitochondria (14). Crude mitochondrial fractions were 
immunoprecipitated with an anti-Rac1 antibody. Western blot analy-
ses showed that Rac1 was coimmunoprecipitated with both MAVS 
and TRADD in wild-type BMDMs. This association was further 
enhanced following SeV infection (Fig. 3A). However, the interac-
tion was significantly decreased in Pggt1b-deficient BMDMs, pre-
sumably because less Rac1 was present in the MAM in the absence 
of protein geranylgeranylation (Fig. 3A). Confocal microscopy cor-
roborated the biochemical results that, upon SeV infection, Rac1 
colocalized with MAVS in wild-type but not Pggt1b-deficient mac-
rophages (Fig. 3, B and C, and fig. S5A). Consistently, PLA analysis 
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indicated that the association of Rac1 with MAVS was abrogated in 
the absence of Pggt1b (Fig. 3, D and E). Additional PLA analysis of 
the Rac1-deficient iBMDMs reconstituted with various mutant forms 
of Rac1 showed that SeV infection induced the association between 
endogenous MAVS with wild-type and G12V Rac1 but not the non- 
geranylgeranylated C189S mutant Rac1 (Fig. 3, F and G). Together, 
these data indicate that Rac1 engagement with MAVS signalosome 
depends on protein geranylgeranylation.
Overexpression of MAVS in the absence of viral infection can acti-
vate TBK1 and IKK and induce transcription of type I interferons (2). 
When ectopically expressed in 293T cells together with MAVS and an 
interferon- (IFN-) luciferase reporter, wild-type and the constitutively 
active G12V but not the C189S non-geranylgeranylated Rac1 mutant 
inhibited MAVS-induced IFN- luciferase reporter activity (Fig. 3H). 
Unlike the wild-type and G12V Rac1, the non-  geranylgeranylated 
C189S mutant Rac1 was not associated with MAM-containing crude 
mitochondrial fractions when ectopically expressed in 293T cells (Fig. 3I). 
In addition to MAVS, overexpression of the MAVS downstream signal-
ing components TBK1 or IRF3 can also activate IFN- reporters. When 
coexpressed, Rac1 inhibited MAVS- but not TBK1- or IRF3-induced 
IFN- luciferase reporter activity (fig. S5B). These results imply that 
Rac1 acts on MAVS, but not its downstream signaling components, to 
inhibit the RLR- mediated innate immune response.
It is of note that the constitutively active G12V Rac1 seemed to 
associate more with MAVS than the wild-type Rac1 in PLA (Fig. 3, 
 F and G). When ectopically expressed, G12V Rac1 more potently 
inhibited MAVS-induced IFN- reporter activity than the wild-type 
Rac1 (Fig. 3H), suggesting that the Rac1 effector function likely 
plays a role in its MAVS-inhibiting activity. To further explore this, 
MAVS−/− iBMDMs or those reconstituted with wild-type MAVS 
(MAVS−/− + MAVS) were pretreated with the clostridial glucosyla-
tion toxin TcsL that specifically inactivates Rac and Cdc42 effector 
function by modifying their switch region (31). Since Rac2 and Cdc42 
are not involved in MAVS signaling (Fig. 2, A and B, and fig. S2J), 
the outcome of TcsL treatment in this experimental setting was most 
likely attributed to the inactivation of Rac1. TcsL treatment led to 
increased Ifnb1 and Il6 transcription upon SeV infection and en-
hanced activation of IRF3 and IKK only in the MAVS-reconstituted, 
but not the MAVS−/− parental iBMDM cell line (fig. S5, C to E). 
These observations further demonstrate that Rac1 effector function 
is required for inhibiting MAVS signaling. Using different truncated 
mutant forms of MAVS, the portion of MAVS interacting with Rac1 
has been mapped to the proline-rich region (Fig. 3J). Together, these 
data indicate that MAM-localized Rac1 directly engages with the 
MAVS signalosome and that Rac1 inhibition of MAVS signaling de-
pends on protein geranylgeranylation and its effector function.
MAM-localized Rac1 inhibits MAVS aggregation 
and activation by limiting MAVS K63 ubiquitination
When activated, MAVS forms functional, prion-like aggregates to 
activate downstream signaling kinases such as TBK1 and IKK (3). 
We reasoned that augmented MAVS signaling in the absence of protein 
geranylgeranylation might be caused by increased MAVS aggregation. 
MAVS aggregates are resistant to detergent in radioimmunoprecip-
itation assay (RIPA) buffer and therefore would not be recovered in 
RIPA-soluble extracts (3). Western blot detected less MAVS in RIPA 
buffer extracts of Pggt1b-deficient BMDMs compared to that of wild-
type control at 3 hours following SeV infection (Fig. 4, A and B). This 
observation suggests that MAVS aggregates form with a faster kinetics 
in Pggt1b-deficient BMDMs than wild-type control cells. To further 
inspect MAVS aggregation, mitochondrial crude extracts were re-
solved by semidenaturing detergent agarose gel electrophoresis 
(SDD-AGE) (3). Before SeV infection, there was a substantial amount 
of aggregated MAVS in the Pggt1b-deficient BMDMs compared to 
almost none in wild-type control BMDMs (Fig. 4C). Viral infection 
increased the amount of MAVS aggregates in both genotypes. However, 
there were substantially more viral infection–induced MAVS aggre-
gates in the Pggt1b-deficient BMDMs than in wild-type controls 
(Fig. 4C). Inactivation of Rac1 effector function with the clostridial 
toxin TcsL also led to increased MAVS aggregation in MAVS-deficient 
iBMDMs reconstituted with a hemagglutinin (HA)–tagged wild-
type MAVS (fig. S6A). SDD-AGE analysis of wild-type and Rac1−/− 
iBMDMs indicated that Rac1 deficiency promotes SeV-induced 
MAVS aggregation. When Rac1−/− iBMDMs were reconstituted 
with various forms of Rac1, only wild-type or G12V but not the non- 
geranylgeranylated C189S Rac1 inhibited SeV-induced MAVS aggre-
gation (fig. S6B). Together, we conclude that Rac1 inhibits SeV-induced 
MAVS aggregation in a protein geranylgeranylation–dependent 
manner.
It has been shown recently that K63-linked ubiquitination of MAVS 
plays an important role in promoting MAVS aggregation (32). We 
speculated that enhanced MAVS aggregation might be due to in-
creased K63-linked MAVS ubiquitination in the absence of Pggt1b. 
To test this hypothesis, MAVS immunoprecipitates from total cell 
lysate of SeV- or mock-infected BMDMs were probed with an anti- 
ubiquitin antibody. SeV-induced MAVS ubiquitination was substan-
tially enhanced in Pggt1b-deficient BMDMs compared to wild-type 
controls. Only K63-linked, but not K48-linked, ubiquitination of 
MAVS was enhanced in Pggt1b-deficient cells (Fig. 4D). These ob-
servations indicate that protein geranylgeranylation inhibits MAVS 
aggregation, at least in part, by suppressing MAVS K63-linked 
ubiquitination.
To explore whether protein geranylgeranylation inhibits MAVS 
ubiquitination through Rac1 effector function, MAVS was immu-
noprecipitated from wild-type primary BMDMs pretreated with or 
without TcsL followed by infection with mock or SeV. Treatment 
with TcsL, which presumably inactivates Rac1, caused increased 
ubiquitination of MAVS in comparison to untreated cells. More spe-
cifically, the increased MAVS ubiquitination was Lys63- but not 
Lys48-linked (fig. S6C). Together, these data further support the idea 
that Rac1 inhibits SeV-induced MAVS K63-linked ubiquitination 
and aggregation.
MAM-localized Rac1 limits the interaction between MAVS 
and the E3 ligase Trim31
Trim31, a ring domain–containing E3 ligase that belongs to the tri-
partite motif family proteins, has recently been shown to catalyze 
MAVS K63 ubiquitination upon RNA virus infection (32). The in-
creased ubiquitination of MAVS in Pggt1b-deficient cells prompted 
us to investigate whether MAM-localized Rac1 affects the interac-
tion between Trim31 and MAVS in a protein geranylgeranylation–
dependent manner. Before viral infection, there was a stronger 
association between endogenous Trim31 and MAVS in Pggt1b-deficient 
cells compared to almost none in wild-type controls (Fig. 4, E and F). 
SeV infection induced a substantially higher amount of Trim31-
MAVS foci in Pggt1b-deficient cells compared to wild-type controls 
(Fig. 4, E and F). When coexpressed in 293T cells, a robust interac-
tion between Trim31 and MAVS was detected by Western blot. 
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This interaction was inhibited by wild-type and, more profoundly, 
the G12V mutant Rac1, but not by the non-geranylgeranylated C189S 
Rac1 (Fig. 4G). To further investigate the role of Rac1 in the regula-
tion of Trim31-MAVS interaction, MAVS-deficient iBMDMs re-
constituted with Myc-tagged MAVS (Myc-MAVS iBMDMs) were 
pretreated with TcsL to inactivate Rac1 effector function, followed 
by infection with mock or SeV. MAVS was immunoprecipitated 
with anti-Myc antibody. Western blot analysis showed that inacti-
vation of Rac1 by TcsL substantially enhanced the interaction be-
tween Trim31 and MAVS (fig. S6D), suggesting that inhibition of 
the interaction between Trim31 and MAVS by Rac1 depends on its 
effector function. PLA analysis of Rac1−/− iBMDMs reconstituted 
with various mutant forms of Rac1 indicated that only wild-type 
and G12V Rac1 efficiently inhibited MAVS-Trim31 association, 
whereas C189S Rac1 failed to do so (fig. S6, E and F). Consistently, 
when K63-ubiquitin was included in the ectopic expression combi-
nation in 293T cells, Trim31-mediated K63-linked ubiquitination of 
MAVS was inhibited by wild-type and G12V Rac1, but not by the 
non-geranylgeranylated C189S Rac1 (Fig. 4H). Together, we con-
clude that protein geranylgeranylation enables Rac1 inhibition of 
MAVS ubiquitination, aggregation, and activation by limiting the 
MAVS-Trim31 interaction.
Fig. 4. MAM-localized Rac1 inhibits Trim31-MAVS interaction and subsequent MAVS Lys63-linked ubiquitination, aggregation, and activation upon RNA virus 
infection. (A) Immunoblot of MAVS and Pggt1b in the RIPA-soluble fractions and WCL of BMDMs infected with SeV. (B) Densitometry of MAVS relative to that of -actin 
in the RIPA-soluble fractions and WCL of (A). (C) Anti-MAVS immunoblot of crude mitochondrial extracts of BMDMs infected with SeV for 4 hours and resolved by SDD-AGE 
(top) or total cell lysate of BMDMs resolved by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) (bottom). (D) Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs infected 
with SeV for 4 hours were lysed, boiled, and sheared by sonication. After centrifugation, supernatants were immunoprecipitated with an anti-MAVS antibody and probed 
with pan-ubiquitin, K63-, or K48-ubiquitin–specific antibodies. Numbers below lanes indicate densitometry relative to -actin. (E and F) PLA confocal images for MAVS 
and TRIM31 (red) in BMDMs 4 hours after SeV infection. Cells were counterstained with DAPI (blue). Scale bars, 10 m (E); (F) quantification of PLA foci per cell in (E) (n = 20 cells), 
*P < 0.05, ****P < 0.0001 (two-way ANOVA). (G) Immunoblot of total cell lysate (bottom) or anti-Myc immunoprecipitates (top) of 293T cells transfected with Myc-tagged 
Mavs and Flag-tagged Trim31 together with the wild-type, G12V, or C189S mutant form of Rac1. (H) Immunoblot of total cell lysate (bottom) or anti-Myc immunoprecip-
itates (top) of 293T cells transfected with Myc-tagged Mavs, Flag-tagged Trim31, and HA-tagged K63-ubiqutin together with the wild-type, G12V, or C189S mutant form 
of Rac1. Data are representative of three independent biological experiments.
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Rac1 facilitates the recruitment of caspase-8 and cFLIPL 
to the MAVS signalosome and promotes Ripk1 cleavage
Within the MAVS signalosome, Ripk1 is K63-ubiquitinated upon 
RNA virus infection. Ubiquitinated Ripk1 promotes the MAVS- 
mediated innate immune response (5). Ubiquitination also renders 
Ripk1 susceptible to cleavage by the caspase-8–cFLIPL heterodimer into 
a 37KD fragment that inhibits MAVS signaling (8). SeV infection–
induced Ripk1 cleavage into the 37KD fragment was impaired 
in Pggt1b-deficient macrophages compared to wild-type controls 
(Fig. 5A). Consistently, inactivation of Rac1 with the bacterial toxin 
TcsL also compromised Ripk1 cleavage upon SeV infection (fig. S7, 
A and B). These observations imply that protein geranylgeranylation 
and Rac1 restrict MAVS signaling by promoting Ripk1 cleavage.
When activated, aggregated MAVS recruits Ripk1, TRADD, 
FADD, caspase-8, and cFLIPL to form the MAVS signaling complex—
the TRADDosome. Consistent with the observation that Pggt1b 
deficiency enhances MAVS aggregation and activation, the recruit-
ment of TRADD to MAVS complex was increased in the absence of 
Pggt1b (Fig. 5B). Nevertheless, the recruitment of Ripk1 to MAVS 
was similar between wild-type and Pggt1b-deficient cells (fig. S7, C 
and D). Contrary to TRADD, the recruitment of caspase-8 to the 
MAVS complex upon SeV infection was almost abrogated in the ab-
sence of protein geranylgeranylation (Fig. 5B). Similar to Pggt1b- 
deficient cells, the recruitment of TRADD and FADD to the MAVS 
complex was also enhanced in Rac1-deficient iBMDMs. However, 
the recruitment of caspase-8 and cFLIPL was almost abrogated in 
the absence of Rac1 upon SeV infection (Fig. 5C). Consistently, when 
ectopically expressed in 293T cells, the wild-type and G12V but 
not C189S mutant Rac1 promoted the association between TRADD 
and caspase-8 on mitochondria (Fig. 5D). These data suggest 
that though hyperactivation of MAVS in the absence of Pggt1b 
or Rac1 leads to increased recruitment of TRADD and FADD into 
the MAVS signalosome, the recruitment of negative regulators, 
caspase-8 and cFLIPL, to the TRADDosome depends on Rac1 and pro-
tein geranylgeranylation.
When caspase-8 was immunoprecipitated from mitochondrial 
extracts, the interaction of caspase-8 with cFLIPL was abrogated 
in the absence of Pggt1b (Fig. 5E). It is notable that the association 
between caspase-8 and cFLIPL in the cytosol was not affected by 
Pggt1b deficiency (Fig. 5E). These observations prompted us to 
investigate whether Rac1 also promotes the association of caspase-8 
with cFLIPL on mitochondria. Coexpression of wild-type or the 
constitutively active form of G12V Rac1 substantially increased 
the interaction between ectopically expressed caspase-8 and cFLIPL 
on mitochondria but not that in the cytoplasm, whereas the 
non-geranylgeranylated C189S mutant Rac1 had no such effect 
(Fig. 5F). This result indicates that Rac1 inhibits MAVS signaling 
by promoting the association of caspase-8 with cFLIPL on mitochon-
dria. Consistent with the decreased Ripk1 cleavage (Fig. 5A), 
the MAVS downstream signaling complex immunoprecipitated 
with the anti-TANK antibody (8) was associated with more high–
molecular weight species of Ripk1 (presumably ubiquitinated 
forms) and NEMO in Pggt1b-deficient BMDMs (fig. S7E), lead-
ing to sustained MAVS signaling to TBK1 and IKK (8). Together, 
we conclude that protein geranylgeranylation licenses Rac1 inhibi-
tion of MAVS signaling by facilitating the recruitment of caspase-8 
and cFLIPL to the MAVS complex and by promoting the associa-
tion of caspase-8 with cFLIPL on mitochondria to enable Ripk1 
cleavage.
Myeloid deficiency of Pggt1b improved mice survival  
upon lethal influenza A virus infection
Pandemic, endemic, and seasonal influenza A virus infection cause 
severe morbidity and mortality (33). Alveolar macrophages are among 
the first line of innate immune cells counteracting viral infection in 
the respiratory tract. Lung alveolar macrophages (mAMs) from 
Pggt1bfl/fl Lyz2-Cre or Pggt1b+/+Lyz2-Cre mice were infected with in-
fluenza A/Puerto Rico/8/1934 H1N1 (PR8) virus. The transcription 
of type I interferons and proinflammatory cytokines was signifi-
cantly augmented in Pggt1b-deficient mAMs infected with PR8 virus 
compared to wild-type control cells (Fig. 6, A and B). Pggt1b-deficient 
BMDMs infected with PR8 also produced a higher amount of type I 
interferons and proinflammatory cytokines (fig. S8, A and B). When 
infected with PR8-mNeon influenza A virus (34) at a low multiplicity 
of infection (MOI), the propagation of virus [assessed by the num-
ber of mNeon fluorescence-positive mAMs (Fig. 6, C and D) or by 
reverse transcription polymerase chain reaction (RT-PCR) quanti-
tation of viral M1 and NS1 genes (fig. S8C)] was impaired in Pggt1b- 
deficient BMDMs compared to wild-type controls. In alignment 
with these in vitro observations, Pggt1bfl/flLyz2-Cre mice showed 
improved survival upon intranasal infection with a lethal dose of PR8 
compared to wild-type control mice (Fig. 6E). At the early phase 
(days 2 to 5) after infection, there was significantly more body weight 
loss in Pggt1bfl/fl Lyz2-Cre versus control mice (Fig. 6F, days 1 to 5), 
suggesting a more severe inflammatory response in these mice. 
Lung virus titers were lower in Pggt1bfl/fl Lyz2-Cre mice than in wild-
type control mice on day 3 after infection (Fig. 6G). Consistent with 
that, IFN- and interleukin-6 (IL-6) levels in the lung homogenates 
were higher on day 3 following infection in Pggt1bfl/fl Lyz2-Cre mice 
compared to wild-type control mice (Fig. 6, H and I). Together, 
these data indicate that myeloid deficiency of protein geranylgera-
nylation enhances innate immunity and improves survival upon lethal 
dose of influenza A virus challenge.
The protein geranylgeranylation ligand GGPP is a metabolite of 
the mevalonate pathway. Inhibition of the mevalonate pathway with 
statins may decrease the abundance of GGPP in the cell and impede 
protein geranylgeranylation. Simvastatin-treated mouse BMDMs 
showed enhanced transcription of Infb1 and Il6 upon PR8 infection 
(fig. S8D). Similarly, when infected with PR8, human and mouse 
lung alveolar macrophages (hAMs and mAMs) displayed a higher 
level of transcription of type I interferons and IL-6 following treat-
ment with simvastatin compared to nontreated control cells (Fig. 6, 
J and K). The increase of cytokine production following simvasta-
tin treatment was not as robust as in Pggt1b-deficient cells. This is 
likely due to the fact that Pggt1b expression is almost abrogated in 
Pggt1b- deficient cells, whereas simvastatin may not completely de-
plete GGPP in treated cells. PR8 expansion in mouse alveolar mac-
rophages was also inhibited by simvastatin treatment (Fig. 6L). It is 
known that statins have antiviral activity through various mecha-
nisms (35). Our results indicate that part of the antiviral effect of 
statins may be attributed to its inhibition of GGPP production, im-
pairment of protein geranylgeranylation, and hyperinduction of 
cytokines.
DISCUSSION
The molecular mechanisms underlying the activation of MAVS-mediated 
antiviral innate immunity have been extensively studied. However, 
how such innate immune response is optimally controlled to prevent 
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Fig. 5. MAM-localized Rac1 facilitates the recruitment of caspase-8 and cFLIPL to MAVS signalosome and promotes the cleavage of Ripk1. (A) Immunoblot with 
anti-Ripk1 of cell lysate from BMDMs at different time points after SeV infection and the densitometry of cleaved 37KD Ripk1 fragment relative to that of -actin in the 
WCL. (B and C) Representative PLA confocal images for MAVS and TRADD and Casp-8 in Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs (B) or MAVS and TRADD, FADD, 
Casp-8, and cFLIPL in wild-type (Rac1+/+) and Rac1−/− iBMDMs (C) 4 hours after SeV infection. Cells were counterstained with DAPI (blue). Scale bars, 10 m. Quantification 
of PLA spots per cell is shown in the right panels of (B) and (C) (n = 20 cells). (D) Immunoblot of input (middle and bottom) or anti-Myc immunoprecipitates (top) in mito-
chondrial fractions of 293T cells transfected with Myc-tagged TRADD and Flag-tagged Casp-8 together with the wild-type, G12V, or C189S mutant form of Rac1. (E) Immu-
noblot of anti–caspase-8 immunoprecipitates and input from mitochondrial (mito) or cytosolic (cyto) fractions of BMDMs 4 hours after SeV infection. (F) Immunoblot of 
input (bottom) or anti-Myc immunoprecipitates (top) in mitochondrial (left) or cytosolic (right) fractions of 293T cells transfected with Myc-tagged caspase-8 and Flag-
tagged cFLIPL together with the wild-type, G12V, or C189S mutant form of Rac1. **P < 0.01, ***P < 0.001, ****P < 0.0001 (two-way ANOVA). Data are representative of three 
independent experiments.
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rampant inflammation remains obscure. Here, we identified pro-
tein geranylgeranylation as a crucial molecular mechanism in limiting 
the antiviral innate immune response. Protein geranylgeranylation 
and subsequent palmitoylation target Rac1 into the MAMs. MAM 
localization brings Rac1 to the proximity of MAVS on mitochon-
dria. MAM-associated Rac1 is incorporated into the MAVS sig-
naling complex and inhibits MAVS K63-linked ubiquitination, 
aggregation, and activation by inhibiting the interaction between 
MAVS and the E3 ligase Trim31. MAM-associated Rac1 also facili-
tates the recruitment of caspase-8 and cFLIPL to the MAVS signal-
ing complex and promotes the association between caspase-8 and 
cFLIPL that cleaves Ripk1 to terminate MAVS signaling. A graphic 
summary is shown in fig.S9.
MAVS aggregation plays a central role in RLR-mediated antivi-
ral immune response (3). For many years since the discovery of MAVS, 
the molecular mechanisms that prevent spontaneous MAVS aggre-
gation on mitochondria in unprovoked cells remain enigmatic. We 
have observed that, in the absence of Pggt1b or Rac1, MAVS forms 
aggregates spontaneously without viral infection. Consistent with 
this observation, elevated levels of activated TBK1 were detected in 
unprovoked Pggt1b-deficient macrophages but not in wild-type 
control cells. Although this elevated level of TBK1 activities in 
Pggt1b- deficient cells is not sufficient to drive detectable transcrip-
tion of type I interferons and proinflammatory cytokines, it might 
greatly diminish the threshold to initiate an antiviral innate immune 
response. Our results support the notion that protein geranylgera-
nylation, together with the GGTase-I substrate Rac1, constitutes a 
key molecular mechanism in keeping MAVS from spontaneous ag-
gregation and activation on mitochondria.
MAVS-orchestrated signaling is self-limiting through the func-
tion of caspase-8 (8) and cFLIPL (7). MAVS signaling resembles that 
of death receptor in which death domain–containing proteins TRADD, 
FADD, Ripk1, caspase-8, and cFLIPL are recruited to MAVS, form-
ing a complex termed TRADDosome (4). Upon activation, TRADD 
and FADD are recruited into the MAVS signalosome (1, 4). FADD 
further recruits caspase-8 (8) and cFLIPL through the death effector 
domain homophilic interaction to form a heterodimer that cleaves 
Ripk1 and terminates MAVS signaling. Consistently, cells deficient 
for caspase-8 or cFLIPL showed an enhanced innate immune re-
sponse to SeV infection or transfected RNA (7, 8). We showed here that 
Fig. 6. Myeloid Pggt1b deficiency better protects mice from lethal PR8 challenge. (A and B) Quantitative RT-PCR analysis of Ifnb1, Ifna4, Il6, and Tnf in murine alveolar 
macrophages (mAMs) 9 hours after acute infection with influenza A virus (PR8, 1 MOI). (C and D) Fluorescence microscopy of mAMs 24 hours after infection with a PR8-mNeon 
strain of (0.01 MOI) containing TPCK-trypsin (1 g/ml) (C) and percentage of mNeon-positive cells (D). (E and F) Survival curves (E) and body weights (F) of Pggt1b+/+Lyz2-Cre 
or Pggt1bfl/f Lyz2-Cre mice infected with 50 plaque-forming units (PFU) PR8 (n = 16); results are pooled together from two independent biological experiments. (G to I) Viral 
titer (G), IFN- (H), and IL-6 (I) levels in lung homogenates from mice 3 days after infection with 50 PFU of PR8 (n = 8 per group). (J) Quantitative RT-PCR analysis of IFNB1 
and IFNA1 in mock or 10 M simvastatin-treated human lung alveolar macrophages (hAMs) 9 hours after infection with 1 MOI PR8. DMSO, dimethyl sulfoxide. (K) Quanti-
tative RT-PCR of Ifnb1 and Il6 in mouse lung alveolar macrophages (mAMs) pretreated with 10 M simvastatin overnight followed by PR8 (1 MOI) infection for 9 hours. 
(L) Quantitative RT-PCR of IAV viral genes M1 and NS1 in mAMs pretreated with simvastatin overnight followed by infection with PR8 (0.01 MOI) containing TPCK-trypsin 
(1 g/ml) for 24 hours. **P <0.01, ***P <0.001, ****P <0.0001 (two-way ANOVA). Data are representative of three independent biological experiments.
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Rac1 is an integral component of the MAVS signalosome. MAM-localized 
Rac1 is required for the recruitment of caspase-8 and cFLIPL to 
TRADDosome. Rac1 promotes the heterodimerization between 
caspase-8 and cFLIPL within the TRADDosome and facilitates sub-
sequent Ripk1 cleavage. Our results indicated that the self-limiting 
capacity of MAVS signalosome depends on Rac1 and protein gera-
nylgeranylation.
Our data elucidated the molecular mechanisms by which protein 
geranylgeranylation suppresses innate immunity to RNA virus in-
fection. Protein geranylgeranylation uses GGPP, a mevalonate path-
way metabolite, as a ligand. Treatment of human and mouse alveolar 
macrophages with statins enhances innate immunity to influenza A 
virus infection. Statins have been shown with antiviral activities 
through various mechanisms (35). Our results indicate that at least 
part of the statins’ antiviral effects can be attributed to inhibition of 
protein geranylgeranylation.
MATERIALS AND METHODS
Mice
Pggt1bfl/fl Lyz2-Cre mice were described previously (17). Rhoafl/fl 
Lyz2Cre mouse bones were provided by M. Kloc of Houston Methodist 
Hospital. Littermate controls were used in the experiments. Mouse 
strains were maintained under specific pathogen–free condi-
tions in the animal facility at Duke University, and the animal pro-
tocols were carried out in accordance with the guidelines set forth 
by the Institutional Animal Care and Use Committee of Duke 
University.
Transfections of BMDMs
Bone marrow cells from wild-type and various knockout mice were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% 
fetal bovine serum (FBS) and 20% L929 supernatants. For transfection, 
Lipofectamine 2000 reagents (Invitrogen) were used. Before trans-
fection, DMEM was replaced with serum-free media and 5′ppp-dsRNA 
(InvivoGen, catalog no. tlrl-3prna), poly(I:C) LMW (InvivoGen, cata-
log no. tlrl-picw), 2′3′-cGAMP (InvivoGen, catalog no. tlrl-nacga23), 
ISD (InvivoGen, catalog no. tlrl-isdn), or other stimulators- lipid 
complex was added to cells. After 4-hour incubation, cells were 
collected for immunoblot assay or RT-PCR. For Sigma1r knockdown, 
BMDMs were transfected with scramble small interfering RNA (siRNA) 
or siGENOME mouse Sigma1r siRNA (Dharmacon, SMARTpool, 
catalog no. 18391). After 48-hour incubation, transfected cells were 
infected with SeV (50 HA units/ml) for 4 hours and cells were lysed 
for RT-PCR.
Isolation of human and mouse alveolar macrophages
Human bronchoalveolar lavage (BAL) was collected according to a 
protocol approved by the Duke Institutional Review Board com-
mittee as described previously (36). Mouse BAL was collected as 
described previously (37). Bronchoalveolar cells were separated 
from around 10 ml of lavage fluid by centrifugation at 250g for 
7 min. The cell pellet was washed twice with phosphate-buffered saline 
(PBS) and resuspended in RPMI 1640 medium [10% heat-inactivated 
FBS, penicillin (100 U/ml), and streptomycin (100 mg/ml), supplement-
ed with 2 mM glutamine]. Human and murine alveolar macro-
phages were purified by adhering for 90 min at 37°C under 5% CO2 in 
150-cm2 culture flasks. The majority of the adhesive cells were alveolar 
macrophages.
BMDM and MEF cell immortalization and reconstitution
Rac1−/−, Rac2−/−, or MAVS−/− iBMDMs were established according 
to a protocol described previously (17). For reconstitution experiments, 
iBMDMs were infected with retrovirus (pMSCV, Clontech) harbor-
ing complementary DNAs (cDNAs) encoding Myc- or Flag-tagged 
mouse MAVS or Flag-tagged mouse Rac1 wild-type, constitutively 
active (G12V), and C189S mutant. The iBMDM culture was selected 
in BMDM medium with puromycin (5 g/ml). For MEF cells stably 
expressing various Rac1 mutants, wild-type C57BL/6 MEF cells were 
infected with retrovirus harboring cDNAs encoding wild-type, or 
G12V and C189S mutant of Rac1. The MEF culture was selected in 
BMDM medium with puromycin (5 g/ml). Viable cells were used 
for subsequent experiments.
Immunoblot analysis and immunoprecipitation assay
Cells were lysed with RIPA buffer [25 mM tris-HCl (pH 7.4), 150 mM 
NaCl, 5 mM EDTA, 0.1% SDS, 0.5% sodium deoxycholate, and 1% 
Triton X-100] supplemented with protease and phosphatase inhibitors. 
Immunoprecipitation was performed using a previously described 
protocol (38). Antibodies against RhoA (catalog no. 2117), p-IRF3 (cata-
log no. 29047), p-IKK/ (catalog no. 2697S), p-AKT S473 (catalog no. 
4060), p-GSK-3 Ser9 (catalog no. 9322), IKK (catalog no. 2684P), 
pan-AKT (catalog no. 4691), GSK-3 (catalog no. 9315S), RIG-I (cata-
log no. 3743), MAVS (catalog no. 4983), TRADD (catalog no. 3694), 
cFLIP (catalog no. 56343), Ubi (catalog no. 3936), K48 Ubi (catalog 
no. 4289), K63 Ubi (catalog no. 5621), NEMO (catalog no. 2685), 
SIGMA1R (catalog no. 61994), Calnexin (catalog no. 2679), VDAC (cata-
log no. 4866), Myc (catalog no. 2278P), and HA-HRP (catalog no. 2999) 
were from Cell Signaling Technology. Antibodies against IRF3 (cata-
log no. sc-9082), MAVS (catalog no. sc-365334), TANK (catalog no. sc- 
166643), -tubulin (catalog no. sc-23948), and Myc (catalog no. sc-40) 
were from Santa Cruz. Antibodies against Pggt1b (catalog no. 
HPA030646), TRIM31 (catalog no. AV34717), -actin–HRP (catalog 
no. A3854), and Flag (catalog no. F4042) were from Sigma-Aldrich. Anti-
bodies against FACL4 (catalog no. PA5-27137), Alexa Fluor 488 donkey 
anti-mouse (catalog no. A21202), and Alexa Fluor 594 goat anti- rabbit 
(catalog no. A-11037) were from Thermo Fisher Scientific. Anti- 
Rac1 (catalog no. 05-389) was from EMD Millipore Corporation. Anti- 
Ripk1 (catalog no. 610458) was from BD Transduction Laboratories. 
Anti–caspase-8 (catalog no. ALX-804-447) was from Enzo Life Sciences. 
Anti–influenza A nucleoprotein (catalog no. EMS 010) was from Kerafast.
Enzyme-linked immunosorbent assay and  
quantitative RT-PCR
Cell culture supernatants or sera were analyzed by enzyme-linked 
immunosorbent assay (ELISA) for IFN- (BioLegend, catalog no. 
439407) and IL-6 (eBiosciences, catalog no. 555240). A sandwich 
ELISA for mouse IFN- was performed as previously described (39). 
Transcript abundance of cytokines was determined by RT-PCR 
using primers listed in table S1.
Detection of S-palmitoylated Rac1 by acyl-RAC
This procedure was performed with the CAPTUREome S-Palmitoylated 
Protein Kit (Badrilla). Each sample of 2 mg of total cellular protein 
was collected and subjected to acyl-RAC. After blocking free thiols 
with a thiol blocking agent, 30 l of supernatant was saved as the “total 
input.” A palmitoylate thioester linkage–specific reagent is then used to 
cleave the thioester bond and to release the palmitoylate group only. 
Newly liberated thiols are captured with CAPTUREome capture resin. 
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After thorough washing, captured proteins from the resin were eluted 
with a reductant provided in the kit, resolved by SDS–polyacrylamide 
gel electrophoresis, and analyzed by immunoblotting for Rac1.
Ubiquitination assay
The analysis of the ubiquitination of endogenous MAVS in BMDMs 
or overexpressed MAVS in 293T cells (American Type Culture 
Collection) transfected with plasmids encoding mouse Myc-MAVS 
or that together with HA-K63 ubiquitin, mouse Flag-Trim31, and 
Rac1 and its mutant forms was performed according to a protocol 
described previously (40). Briefly, cells were collected with com-
plete cell lysis buffer [2% SDS, 150 mM NaCl, and 10 mM tris-HCl 
(pH 8.0)] with 2 mM sodium orthovanadate, 50 mM sodium fluo-
ride, and protease inhibitors and then boiled for 10 min. Cells were 
immediately sheared with sonication, diluted with dilution buffer 
[10 mM tris-HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, and 1% Triton], 
and incubated at 4°C for 30 min with rotation. After centrifugation 
for 30 min at 20,000g, supernatants were immunoprecipitated with 
the anti-MAVS or anti-Myc–specific antibodies and analyzed by 
immunoblot with anti-ubiquitin (total), anti-ubiquitin (K48), anti- 
ubiquitin (K63), or anti-HA antibodies.
Semidenaturing detergent agarose gel electrophoresis
SDD-AGE was performed as described previously (3).
Viral infection and plaque assay
For in vitro infection, SeV (Charles River Laboratories, catalog no. 
10100816) and MCMV were diluted to indicated concentrations 
with DMEM serum-free media. After washing with Dulbecco’s PBS, 
cultured BMDMs were infected with virus for 1 hour and then 
changed with DMEM with 10% FBS. For H1N1 influenza A virus 
Puerto Rico/08/1934 (IAV PR8) infection, BMDMs were infected 
with IAV PR8 in Opti-MEM supplemented with 1% bovine serum 
albumin (BSA). Single-round acute infections were performed at an 
MOI of 1.0, while multicycle spreading infections were performed 
at an MOI of 0.01. Cells were incubated with infectious medium for 
1 hour before this was replaced with DMEM supplemented with 1% 
BSA and antibiotics. For multicycle spreading infections, postinfection 
media were also supplemented with TPCK-treated trypsin (1 g/ml; 
Sigma-Aldrich, catalog no. T8802).
Animal infections and plaque assays were performed as described 
previously (34). Briefly, age- and sex-matched Pggt1b+/+ Lyz2-Cre 
and Pggt1bfl/fl Lyz2-Cre mice were anesthetized and infected with 
influenza virus A/PR/8/34 (IAV, 50 PFU per mouse) by intranasal 
administration. Mice were weighed daily and euthanized once their 
body weight reached 80% of starting weight. Mice were euthanized 
3 days after infection, and lung homogenates were generated for 
plaque assay and cytokine analyses on day 3.
Lung viral titer was determined via standard plaque assay pro-
cedures on Madin-Darby canine kidney cells. Cells were incubated 
with diluted virus suspension for 1 hour before removing the virus 
and applying the agar overlay. Cells were then incubated for 72 hours 
before being fixed in 4% paraformaldehyde (PFA) for at least 
4 hours. After aspirating off PFA and removing the agar layer, cells 
were incubated with an anti–influenza A nucleoprotein antibody 
overnight. After washing and incubating with a secondary anti-
body, cells were then washed and incubated in a TrueBlue reagent 
(SeraCare, catalog no. 5510-0050) for 30 min to allow for the staining 
of plaques.
Luciferase assays
Luciferase activity was measured with the Dual-Luciferase Reporter 
Assay system according to the manufacturer’s instructions (Promega, 
catalog no. E1910). Data were normalized for transfection efficiency by 
calculating the ratio between firefly luciferase activity and Renilla 
luciferase activity.
Deconvolution of confocal microscopy and 
colocalization analysis
Cells grown on glass coverslips were infected with or without SeV 
for 4 hours and incubated with 200 nM MitoTracker Red CMXRos 
(Thermo Fisher Scientific, catalog no. M7512) for 20 min at 37°C. The 
cells were then fixed in ice-cold methanol for 15 min at −20°C, 
permeabilized with 0.3% Triton X-100, and blocked with 10% FBS. The 
cells were stained with the indicated primary antibodies, followed 
by incubation with fluorescent dye–conjugated secondary antibodies. 
Nuclei were counterstained with 4′,6-diamidino-2-phenylindole 
(Sigma-Aldrich, catalog no. D9542). Imaging of the cells was carried 
out using a Leica confocal microscope (Leica SP8). Nine images of 
stacks were collected in 0.15-m Z-steps. The stacks were further 
subjected to three-dimensional deconvolution using the Huygens 
Essential software (Scientific Volume Imaging). Deconvolved images 
were exported as single-channel tiff images. Colocalization analysis 
was performed using Fiji software [National Institutes of Health 
(NIH), USA].
Proximity ligation assay
Primary Pggt1b+/+ Lyz2-Cre and Pggt1bfl/fl Lyz2-Cre BMDMs, 
Rac1−/− iBMDM, or that reconstituted with various mutant forms 
of Rac1 were fixed with ice-cold 100% methanol, permeabilized 
with 0.3% Triton X-100, and blocked with 5% goat serum. PLA 
was performed according to the manufacturer’s instructions 
(Duolink, Sigma-Aldrich). Fluorescent red spots were detected by 
using an upright confocal microscope, Leica SP8 (Leica). Quantifi-
cation of interaction spots per cell was performed using the ImageJ 
software.
Quantification and statistical analyses
Two-way ANOVA multiple-factor comparison was performed 
using Prism software (GraphPad Software Inc.).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/5/eaav7999/DC1
Fig. S1. Protein geranylgeranylation has no effect on DNA virus–induced antiviral innate 
immune response.
Fig. S2. Rac1 but not RhoA or Cdc42 suppresses MAVS signaling in a protein 
geranylgeranylation–dependent manner.
Fig. S3. Protein geranylgeranylation targets Rac1 to MERC ER membranes upon RLR 
engagement.
Fig. S4. Chaperon but not the signaling function of SIGMA1R and Rac1 palmitoylation is 
important for anchoring Rac1 to MERC ER membranes.
Fig. S5. Rac1 directly engages MAVS signalosome and inhibits MAVS signaling in a protein 
geranylgeranylation–dependent manner.
Fig. S6. MERC-localized Rac1 inhibits Trim31-MAVS interaction and subsequent MAVS 
Lys63-linked ubiquitination, aggregation, and activation upon RNA virus infection.
Fig. S7. MERC-localized Rac1 promotes cleavage of Ripk1 and the association of TANK with 
ubiquitinated Ripk1.
Fig. S8. Pggt1b deficiency and Statin pretreatment in BMDMs enhance antiviral innate 
immune response after influenza A virus PR8 challenge.
Fig. S9. Graphic summary.
Table S1. Primers for quantitative RT-PCR.
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